ATE529133T1 - Topisches präparat - Google Patents
Topisches präparatInfo
- Publication number
- ATE529133T1 ATE529133T1 AT05768591T AT05768591T ATE529133T1 AT E529133 T1 ATE529133 T1 AT E529133T1 AT 05768591 T AT05768591 T AT 05768591T AT 05768591 T AT05768591 T AT 05768591T AT E529133 T1 ATE529133 T1 AT E529133T1
- Authority
- AT
- Austria
- Prior art keywords
- present
- mast cell
- cell degranulation
- degranulation inhibitor
- preparation containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004238167 | 2004-08-18 | ||
| JP2005021549 | 2005-01-28 | ||
| PCT/JP2005/014468 WO2006018997A1 (ja) | 2004-08-18 | 2005-08-01 | 外用剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE529133T1 true ATE529133T1 (de) | 2011-11-15 |
Family
ID=35907387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05768591T ATE529133T1 (de) | 2004-08-18 | 2005-08-01 | Topisches präparat |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7592371B2 (de) |
| EP (1) | EP1782831B1 (de) |
| JP (1) | JP4843824B2 (de) |
| AT (1) | ATE529133T1 (de) |
| WO (1) | WO2006018997A1 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090264664A1 (en) * | 2005-10-21 | 2009-10-22 | Medrx Co., Ltd. | Preparation for external application comprising salt of mast cell degranulation inhibitor having carboxyl group with organic amine |
| JP2008031079A (ja) * | 2006-07-28 | 2008-02-14 | Sigma Soyaku Kk | 花粉症に伴う症状を抑えるための薬剤 |
| WO2008093686A1 (ja) * | 2007-01-29 | 2008-08-07 | Medrx Co., Ltd. | 非ステロイド系抗炎症薬と有機アミン化合物との塩とその用途 |
| JP5670008B2 (ja) * | 2007-01-31 | 2015-02-18 | 大正製薬株式会社 | アダパレン含有外用剤組成物 |
| EP2311498A4 (de) * | 2008-08-05 | 2013-07-24 | Medrx Co Ltd | Externes präparat mit einem fettsäuresalz oder einem benzoesäuresalz aus einer basischen pharmakologischen wirkstoffkomponente sowie verfahren zu seiner herstellung |
| AU2013239114B2 (en) * | 2012-03-30 | 2017-07-20 | Nuformix Limited | Tranilast compositions and cocrystals |
| AU2015258472B2 (en) * | 2014-05-15 | 2020-05-21 | Grunenthal Gmbh | Device and formulation for topical treatment of pain affecting the vulvar area of the female human genital organ |
| PL3273952T3 (pl) | 2015-03-26 | 2022-11-14 | SEN-JAM Pharmaceutical LLC | Kombinacja naproksenu i feksofenadyny w celu zahamowania objawów związanych z zatruciem alkoholem |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4748022A (en) * | 1985-03-25 | 1988-05-31 | Busciglio John A | Topical composition |
| US4866050A (en) * | 1988-04-27 | 1989-09-12 | Ben Amoz Daniel | Ultrasonic transdermal application of steroid compositions |
| JPH06128153A (ja) * | 1992-10-16 | 1994-05-10 | Kissei Pharmaceut Co Ltd | トラニラスト軟膏組成物およびその製造方法 |
| JPH08295624A (ja) * | 1995-04-26 | 1996-11-12 | Read Chem Kk | プラスター基剤、その製造方法、該基剤を使用した外用貼 付剤 |
| DE974350T1 (de) | 1996-02-07 | 2001-01-25 | Kissei Pharmaceutical Co., Ltd. | Tranilast enthaltendes externum und verfahren zu dessen herstellung |
| US6429228B1 (en) * | 1996-10-14 | 2002-08-06 | Kowa Company, Ltd. | Local anesthetic for external use |
| US20010004644A1 (en) | 1997-07-21 | 2001-06-21 | Levin Bruce H. | Compositions, kits, apparatus, and methods for inhibiting cephalic inflammation |
| KR20010022041A (ko) * | 1997-07-21 | 2001-03-15 | 클래스 빌헬름슨 | 뇌 신경혈관 장애 및 근육성 두통 억제용 조성물, 키트 및방법 |
| US7799337B2 (en) | 1997-07-21 | 2010-09-21 | Levin Bruce H | Method for directed intranasal administration of a composition |
| US6432986B2 (en) | 1997-07-21 | 2002-08-13 | Bruce H. Levin | Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches |
| JP4295841B2 (ja) | 1998-05-11 | 2009-07-15 | アピ株式会社 | 抗アレルギー外用剤 |
| JP4684404B2 (ja) | 2000-10-26 | 2011-05-18 | 第一三共株式会社 | 消炎鎮痛外用剤組成物 |
| US6468557B1 (en) * | 2001-01-05 | 2002-10-22 | Alphamed Pharmaceutical Corp. | Method for treating infectious viral diseases |
| JP4106232B2 (ja) * | 2001-05-09 | 2008-06-25 | ロート製薬株式会社 | 医薬組成物 |
| JP4176358B2 (ja) | 2002-03-01 | 2008-11-05 | 天藤製薬株式会社 | 痔疾用医薬組成物 |
| AU2003256284A1 (en) * | 2002-06-20 | 2004-01-06 | Orapharma, Inc. | Rapidly disintegrating formulations for treating or preventing mucositis |
| ES2397574T3 (es) * | 2002-07-30 | 2013-03-08 | Omeros Corporation | Procedimiento y soluciones de irrigación oftalmológica |
| US7166641B2 (en) | 2002-10-02 | 2007-01-23 | Yung Shin Pharmaceutical Industrial Co., Ltd. | Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same |
| JP2004161625A (ja) * | 2002-11-11 | 2004-06-10 | Noevir Co Ltd | 水性スティック状皮膚疾患治療用外用剤 |
-
2005
- 2005-08-01 AT AT05768591T patent/ATE529133T1/de not_active IP Right Cessation
- 2005-08-01 US US11/660,393 patent/US7592371B2/en not_active Expired - Fee Related
- 2005-08-01 JP JP2006531611A patent/JP4843824B2/ja not_active Expired - Fee Related
- 2005-08-01 WO PCT/JP2005/014468 patent/WO2006018997A1/ja not_active Ceased
- 2005-08-01 EP EP05768591A patent/EP1782831B1/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2006018997A1 (ja) | 2008-05-08 |
| JP4843824B2 (ja) | 2011-12-21 |
| EP1782831B1 (de) | 2011-10-19 |
| US7592371B2 (en) | 2009-09-22 |
| EP1782831A1 (de) | 2007-05-09 |
| EP1782831A4 (de) | 2009-12-02 |
| WO2006018997A1 (ja) | 2006-02-23 |
| US20080108700A1 (en) | 2008-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5590929A2 (es) | Derivados de acetileno que tienen actividad antagonica de mgiur5 | |
| NO20080068L (no) | Topisk unguale formuleringer | |
| UY27729A1 (es) | Inhibidores de quinasas. | |
| DE602005026508D1 (de) | Monozyklische heterozyklen als kinase-hemmer | |
| ATE479013T1 (de) | Integriertes magnetisches vermessungswerkzeug | |
| BRPI0511621A (pt) | compostos orgánicos | |
| CL2009000782A1 (es) | Metodo que comprende un compuesto derivado de oximetilen-arilo sustituido, inhibidores de dpp-iv; y su uso en el tratamiento de la diabetes y disminucion de trigliceridos, entre otras enfermedades. | |
| NO20071127L (no) | Triazoloftalaziner | |
| NO20082298L (no) | Kaliumkanalinhibitorer | |
| EA200701396A1 (ru) | Триазолофталазины в качестве ингибиторов pde-2 | |
| AR029696A1 (es) | Derivados de ciclopentil-glutaramida como inhibidores de endopeptidasa neutra | |
| ATE529133T1 (de) | Topisches präparat | |
| ATE404536T1 (de) | Substituierte chinolinderivate als inhibitoren von mitotischem kinesin | |
| CR7717A (es) | Nuevos inhibidores biciclicos de hormona sensitiva a la lipasa | |
| EA200801607A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
| CR9472A (es) | Derivados de aminoacidos | |
| ATE465159T1 (de) | (s)-(-)-1-(4-fluorisochinolin-5-yl)sulfonyl-2- methyl-1,4-homopiperazinhydrochlorid- dihydrat | |
| CO5700779A2 (es) | Un proceso para la preparación de oxi-(1h)-quinolin-2-onas 5-(haloacetil)-8-sustituidas | |
| BR0311223A (pt) | Método para o uso de derivados de piranindol para tratar infecção pelo vìrus da hepatite c | |
| ATE417849T1 (de) | Pyrazoloä4,3-düpyrimidine | |
| BRPI0509926A (pt) | imidazóis | |
| ATE512967T1 (de) | Als kinaseinhibitoren geeignete pyrrolotriazinverbindungen | |
| NO20091771L (no) | Ny krystall av (S)-(+)-2-(2-klorfenyl)-2-hydroksyetylkarbamat | |
| DE602004011946D1 (de) | Alkalisalze von protonenpumpen-hemmern | |
| ATE480542T1 (de) | Pyrroloä1,2-düä1,2-4ütriazin als inhibitoren von c-jun-n-terminal-kinasen (jnk) und p-38-kinasen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |